FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4307182535> ?p ?o ?g. }

• W4307182535 abstract "Hepatic metastases are a poor prognostic factor of colorectal carcinoma (CRC) and new strategies to reduce the risk of liver CRC colonization are highly needed. Herein, we used mouse models of hepatic metastatization to demonstrate that the continuous infusion of therapeutic doses of interferon-alpha (IFNα) controls CRC invasion by acting on hepatic endothelial cells (HECs). Mechanistically, IFNα promoted the development of a vascular antimetastatic niche characterized by liver sinusoidal endothelial cells (LSECs) defenestration extracellular matrix and glycocalyx deposition, thus strengthening the liver vascular barrier impairing CRC trans-sinusoidal migration, without requiring a direct action on tumor cells, hepatic stellate cells, hepatocytes, or liver dendritic cells (DCs), Kupffer cells (KCs) and liver capsular macrophages (LCMs). Moreover, IFNα endowed LSECs with efficient cross-priming potential that, along with the early intravascular tumor burden reduction, supported the generation of antitumor CD8+ T cells and ultimately led to the establishment of a protective long-term memory T cell response. These findings provide a rationale for the use of continuous IFNα therapy in perioperative settings to reduce CRC metastatic spreading to the liver.Colorectal cancer remains one of the most widespread and deadly cancers worldwide. Poor health outcomes are usually linked to diseased cells spreading from the intestine to create new tumors in the liver or other parts of the body. Treatment involves surgically removing the initial tumors in the bowel, but patient survival could be improved if, in parallel, their immune system was ‘boosted’ to destroy cancer cells before they can form other tumors. Interferon alpha is a small protein which helps to coordinate how the immune system recognizes and deactivates foreign agents and cancerous cells. It has recently been trialed as a colorectal cancer treatment to prevent tumors from spreading to the liver, but only with limited success. This partly because interferon-alpha is usually administered in high and pulsed doses, which cause severe side effects through the body. Instead, Tran, Ferreira, Alvarez-Moya et al. aimed to investigate whether continuously delivering lower amounts of the drug could be a better approach. This strategy was tested on mice in which colorectal cancer cells had been implanted into the wall of the large intestine. Continuous administration minimized the risk of the implanted cancer cells spreading to the liver while also creating fewer side effects. The team was able to identify an optimum delivery strategy by varying how much interferon-alpha the animals received and when. Further experiments also revealed a new mechanism by which interferon-alpha prevented the spread of colorectal cancer. Upon receiving continuous doses of the drug, a group of liver cells started to generate a physical barrier which stopped cancer cells from being able to invade the organ. The treatment also promoted long-term immune responses that targeted diseased cells while being safe for healthy tissues. If confirmed in clinical trials, these results suggest that colorectal patients undergoing tumor removal surgery may benefit from also receiving interferon-alpha through continuous delivery." @default.
• W4307182535 created "2022-10-29" @default.
• W4307182535 creator A5000023846 @default.
• W4307182535 creator A5003630060 @default.
• W4307182535 creator A5009063829 @default.
• W4307182535 creator A5013573202 @default.
• W4307182535 creator A5020126181 @default.
• W4307182535 creator A5045611883 @default.
• W4307182535 creator A5052002100 @default.
• W4307182535 creator A5053525076 @default.
• W4307182535 creator A5054004186 @default.
• W4307182535 creator A5058353178 @default.
• W4307182535 creator A5059250031 @default.
• W4307182535 creator A5065989929 @default.
• W4307182535 creator A5066430182 @default.
• W4307182535 creator A5076444734 @default.
• W4307182535 creator A5082247556 @default.
• W4307182535 creator A5084242240 @default.
• W4307182535 date "2022-10-25" @default.
• W4307182535 modified "2023-09-30" @default.
• W4307182535 title "Continuous sensing of IFNα by hepatic endothelial cells shapes a vascular antimetastatic barrier" @default.
• W4307182535 cites W117035382 @default.
• W4307182535 cites W1483372876 @default.
• W4307182535 cites W1781806439 @default.
• W4307182535 cites W1865235773 @default.
• W4307182535 cites W1924680600 @default.
• W4307182535 cites W1956714466 @default.
• W4307182535 cites W1964879847 @default.
• W4307182535 cites W1966426192 @default.
• W4307182535 cites W1967982404 @default.
• W4307182535 cites W1971197010 @default.
• W4307182535 cites W1973096186 @default.
• W4307182535 cites W1982027307 @default.
• W4307182535 cites W1985329068 @default.
• W4307182535 cites W1992088744 @default.
• W4307182535 cites W1993455773 @default.
• W4307182535 cites W1995856733 @default.
• W4307182535 cites W1997384271 @default.
• W4307182535 cites W2000495010 @default.
• W4307182535 cites W2003128631 @default.
• W4307182535 cites W2007897263 @default.
• W4307182535 cites W2008988293 @default.
• W4307182535 cites W2017691530 @default.
• W4307182535 cites W2018515313 @default.
• W4307182535 cites W2021187866 @default.
• W4307182535 cites W2021256410 @default.
• W4307182535 cites W2047269521 @default.
• W4307182535 cites W2048819274 @default.
• W4307182535 cites W2063470457 @default.
• W4307182535 cites W2068128522 @default.
• W4307182535 cites W2070050178 @default.
• W4307182535 cites W2074545819 @default.
• W4307182535 cites W2078505577 @default.
• W4307182535 cites W2079634214 @default.
• W4307182535 cites W2083075036 @default.
• W4307182535 cites W2088113798 @default.
• W4307182535 cites W2089828715 @default.
• W4307182535 cites W2099736081 @default.
• W4307182535 cites W2102010795 @default.
• W4307182535 cites W2104135721 @default.
• W4307182535 cites W2110065044 @default.
• W4307182535 cites W2112244490 @default.
• W4307182535 cites W2113847305 @default.
• W4307182535 cites W2114160093 @default.
• W4307182535 cites W2116607009 @default.
• W4307182535 cites W2119938514 @default.
• W4307182535 cites W2121698544 @default.
• W4307182535 cites W2123461995 @default.
• W4307182535 cites W2128402485 @default.
• W4307182535 cites W2130410032 @default.
• W4307182535 cites W2131271579 @default.
• W4307182535 cites W2133773373 @default.
• W4307182535 cites W2134568793 @default.
• W4307182535 cites W2135827695 @default.
• W4307182535 cites W2140372606 @default.
• W4307182535 cites W2144122733 @default.
• W4307182535 cites W2152252241 @default.
• W4307182535 cites W2153109187 @default.
• W4307182535 cites W2155728422 @default.
• W4307182535 cites W2157959759 @default.
• W4307182535 cites W2158257131 @default.
• W4307182535 cites W2165200432 @default.
• W4307182535 cites W2165747522 @default.
• W4307182535 cites W2165897342 @default.
• W4307182535 cites W2167279371 @default.
• W4307182535 cites W2167414337 @default.
• W4307182535 cites W2168541479 @default.
• W4307182535 cites W2172076789 @default.
• W4307182535 cites W2179438025 @default.
• W4307182535 cites W2239828577 @default.
• W4307182535 cites W2244784552 @default.
• W4307182535 cites W2261845727 @default.
• W4307182535 cites W2262355743 @default.
• W4307182535 cites W2288694532 @default.
• W4307182535 cites W2345356016 @default.
• W4307182535 cites W2404259999 @default.
• W4307182535 cites W2412123090 @default.
• W4307182535 cites W2466314544 @default.
• W4307182535 cites W2586859855 @default.
• W4307182535 cites W2588029744 @default.

• next